These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25281507)

  • 1. The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
    Rajala HL; Olson T; Clemente MJ; Lagström S; Ellonen P; Lundan T; Hamm DE; Zaman SA; Lopez Marti JM; Andersson EI; Jerez A; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Haematologica; 2015 Jan; 100(1):91-9. PubMed ID: 25281507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia.
    Jerez A; Clemente MJ; Makishima H; Koskela H; Leblanc F; Peng Ng K; Olson T; Przychodzen B; Afable M; Gomez-Segui I; Guinta K; Durkin L; Hsi ED; McGraw K; Zhang D; Wlodarski MW; Porkka K; Sekeres MA; List A; Mustjoki S; Loughran TP; Maciejewski JP
    Blood; 2012 Oct; 120(15):3048-57. PubMed ID: 22859607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic
    Savola P; Brück O; Olson T; Kelkka T; Kauppi MJ; Kovanen PE; Kytölä S; Sokka-Isler T; Loughran TP; Leirisalo-Repo M; Mustjoki S
    Haematologica; 2018 Feb; 103(2):304-312. PubMed ID: 29217783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic STAT3 mutations in large granular lymphocytic leukemia.
    Koskela HL; Eldfors S; Ellonen P; van Adrichem AJ; Kuusanmäki H; Andersson EI; Lagström S; Clemente MJ; Olson T; Jalkanen SE; Majumder MM; Almusa H; Edgren H; Lepistö M; Mattila P; Guinta K; Koistinen P; Kuittinen T; Penttinen K; Parsons A; Knowles J; Saarela J; Wennerberg K; Kallioniemi O; Porkka K; Loughran TP; Heckman CA; Maciejewski JP; Mustjoki S
    N Engl J Med; 2012 May; 366(20):1905-13. PubMed ID: 22591296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations.
    Rajala HL; Porkka K; Maciejewski JP; Loughran TP; Mustjoki S
    Ann Med; 2014 May; 46(3):114-22. PubMed ID: 24512550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell large granular lymphocyte leukemia and chronic NK lymphocytosis.
    Barilà G; Calabretto G; Teramo A; Vicenzetto C; Gasparini VR; Semenzato G; Zambello R
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):207-216. PubMed ID: 31585621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
    Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
    Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL).
    Sanikommu SR; Clemente MJ; Chomczynski P; Afable MG; Jerez A; Thota S; Patel B; Hirsch C; Nazha A; Desamito J; Lichtin A; Pohlman B; Sekeres MA; Radivoyevitch T; Maciejewski JP
    Leuk Lymphoma; 2018 Feb; 59(2):416-422. PubMed ID: 28633612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic landscape of T-large granular lymphocyte leukemia and chronic lymphoproliferative disorder of NK cells: a single institution experience.
    Fei F; Stehr H; Zehnder JL
    Leuk Lymphoma; 2023 Sep; 64(9):1536-1544. PubMed ID: 37330635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients.
    Barilà G; Teramo A; Calabretto G; Vicenzetto C; Gasparini VR; Pavan L; Leoncin M; Vedovato S; Frigo AC; Facco M; Semenzato G; Zambello R
    Leukemia; 2020 Apr; 34(4):1116-1124. PubMed ID: 31740810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclonal STAT3 mutations solidify clonal dominance.
    Kerr CM; Clemente MJ; Chomczynski PW; Przychodzen B; Nagata Y; Adema V; Visconte V; Lichtin AE; Mustjoki S; Radivoyevitch T; Sekeres MA; Maciejewski JP
    Blood Adv; 2019 Mar; 3(6):917-921. PubMed ID: 30898763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.
    Gattazzo C; Teramo A; Passeri F; De March E; Carraro S; Trimarco V; Frezzato F; Berno T; Barilà G; Martini V; Piazza F; Trentin L; Facco M; Semenzato G; Zambello R
    Haematologica; 2014 Dec; 99(12):1826-33. PubMed ID: 25193965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.
    Ishida F; Matsuda K; Sekiguchi N; Makishima H; Taira C; Momose K; Nishina S; Senoo N; Sakai H; Ito T; Kwong YL
    Cancer Sci; 2014 Mar; 105(3):342-6. PubMed ID: 24350896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell size variations of large granular lymphocyte leukemia: Implication of a small cell subtype of granular lymphocyte leukemia with STAT3 mutations.
    Tanahashi T; Sekiguchi N; Matsuda K; Takezawa Y; Ito T; Kobayashi H; Ichikawa N; Nishina S; Senoo N; Sakai H; Nakazawa H; Ishida F
    Leuk Res; 2016 Jun; 45():8-13. PubMed ID: 27064362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a single-institution cohort of patients with Felty's syndrome and T-cell large granular lymphocytic leukemia in the setting of rheumatoid arthritis.
    Gorodetskiy VR; Sidorova YV; Kupryshina NA; Vasilyev VI; Probatova NA; Ryzhikova NV; Sudarikov AB
    Rheumatol Int; 2021 Jan; 41(1):147-156. PubMed ID: 33280072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate therapy of T-cell large granular lymphocytic leukemia impact of STAT3 mutation.
    Qiu ZY; Fan L; Wang R; Gale RP; Liang HJ; Wang M; Wang L; Wu YJ; Qiao C; Chen YY; Xu W; Qian J; Li JY
    Oncotarget; 2016 Sep; 7(38):61419-61425. PubMed ID: 27542218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic landscape of TCRαβ and TCRγδ T-large granular lymphocyte leukemia.
    Cheon H; Xing JC; Moosic KB; Ung J; Chan VW; Chung DS; Toro MF; Elghawy O; Wang JS; Hamele CE; Hardison RC; Olson TL; Tan SF; Feith DJ; Ratan A; Loughran TP
    Blood; 2022 May; 139(20):3058-3072. PubMed ID: 35015834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical relevance of sensitive and quantitative STAT3 mutation analysis using next-generation sequencing in T-cell large granular lymphocytic leukemia.
    Kristensen T; Larsen M; Rewes A; Frederiksen H; Thomassen M; Møller MB
    J Mol Diagn; 2014 Jul; 16(4):382-92. PubMed ID: 24797340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations.
    Olson KC; Moosic KB; Jones MK; Larkin PMK; Olson TL; Toro MF; Fox TE; Feith DJ; Loughran TP
    Cancer Med; 2020 Sep; 9(18):6533-6549. PubMed ID: 32710512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses.
    Stalika E; Papalexandri A; Iskas M; Stavroyianni N; Kanellis G; Kotta K; Pontikoglou C; Siorenta A; Anagnostopoulos A; Papadaki H; Papadaki T; Stamatopoulos K
    Leuk Lymphoma; 2014 Aug; 55(8):1781-7. PubMed ID: 24180333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.